Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, Single Dose, Three-way Crossover Open Label Pharmacokinetic Parameters Study of AFT Maxigesic IV (Acetaminophen 1000mg + Ibuprofen 300mg/100 mL solution for infusion), Infusion over 15 minutes (One Dose Only), Ultracet (Acetaminophen 325mg + tramadol 37.5mg) Tablets and Dr. Reddy Laboratories Ibuprofen Tablets (Ibuprofen 800mg), after Oral administration to 30 healthy volunteers under fasting conditions

Next Previous
Trial Profile

Randomized, Single Dose, Three-way Crossover Open Label Pharmacokinetic Parameters Study of AFT Maxigesic IV (Acetaminophen 1000mg + Ibuprofen 300mg/100 mL solution for infusion), Infusion over 15 minutes (One Dose Only), Ultracet (Acetaminophen 325mg + tramadol 37.5mg) Tablets and Dr. Reddy Laboratories Ibuprofen Tablets (Ibuprofen 800mg), after Oral administration to 30 healthy volunteers under fasting conditions

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jul 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibuprofen/paracetamol (Primary) ; Ibuprofen; Tramadol/paracetamol
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors AFT Pharmaceuticals

Most Recent Events

  • 11 Jul 2019 Status changed from not yet recruiting to completed.
  • 20 Dec 2018 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top